Epigenica Unveils Breakthrough Epigenetics Platform, Launches First Commercial ChIP-seq Kit for High-throughput, Multiplex Genome-wide Profiling

Almi Invest has made a significant investment in the company Epigenica early in the fall. The company is focused on advancing epigenomics by delivering state-of-the-art epigenetic screening tools. With its multiplexing technology, the company offers its customers more comprehensive information faster, at a fraction of the cost they currently pay for the same knowledge.

Epigenica attended the AI for Health Summit in Paris on November 22. At our booth, shared with EIT Health, we engaged in enlightening conversations with many attendees, fostering a vibrant exchange of ideas.